Seminars in Oncology
Volume 29, Issue 4 , Pages 336-340, August 2002

Mohs micrographically controlled surgery and the treatment of malignant melanoma

Division of Dermatology, University of California, San Diego, School of Medicine, San Diego, CA.

Address correspondence to Constance Nagi, MD, Division of Dermatology (8420), UCSD Medical Center, San Diego, CA 92103-8420.

Abstract 

Mohs micrographic surgery is a technique that offers surgeons and pathologists a means to examine the entire surgical margins of excised cutaneous malignancies in a more complete manner than conventional methods. Initially developed to treat nonmelanoma skin cancers, its use has been expanded to include histologic margin evaluation for treatment of malignant melanoma. Clinical studies demonstrate equivalent or better 5-year survival rates with Mohs surgery compared to conventional wide local excision. For surgical treatment of melanoma, it offers unique advantages for lesions requiring tissue conservation and accurate margin determination, particularly in anatomic sites where cosmetic and functional concerns are of importance (head and neck, hands, and feet), and for large or ill-defined lesions such as lentigo maligna or lentigo maligna melanoma. Semin Oncol 29:336-340. Copyright 2002, Elsevier Science (USA). All rights reserved.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 A.H. is a Howard Hughes Fellow.

PII: S0093-7754(02)50263-3

doi:10.1053/sonc.2002.34111

Seminars in Oncology
Volume 29, Issue 4 , Pages 336-340, August 2002